Home › Research › Topics › av-1451
av-1451
4 studies tagged av-1451, dated 2017-09-14 to 2018-02-09. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake 2018-02-09
- [18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease 2018-02-06
- Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease 2018-01-01
Studies
4 studies carry this tag.
Date range
2017 to 2018
Top journals
- Annals of neurology 1
- Journal of Alzheimer's disease : JAD 1
- Journal of neurology, neurosurgery, and psychiatry 1
- Neurobiology of aging 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
55/100
We examined the relationship between in vivo estimates of tau deposition as measured by 18 F-AV-1451 tau positron emission tomography imaging and cross-sectional cortical thickness, as well as rates of antecedent cortical thinning measured from magnetic resonance imaging in individuals with and without evidence of cerebral amyloid in 63 participants from the Alzheimer's Disease Neuroimaging Initiative study, including 32 cognitively normal individuals (mean age 74 years), 27 patients with mild cognitive impairment (mean age 76.8 years), and 4 patients diagnosed with Alzheimer's disease (mean age 80 years).
-
This study demonstrates considerable variability in [ 18 F]AV-1451 tau-PET uptake in AD, but shows that a straightforward clustering based on entorhinal and cortical uptake maps well onto age and clinical presentation in AD.
-
Tau deposition is closely related to clinical presentation in atypical AD with age playing a role in determining the degree of cortical tau deposition.
-
[ 18 F]AV-1451 binds in vivo regions that are likely to contain TDP-43 and not significant tau pathology.